These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome. Büscher AK; Beck BB; Melk A; Hoefele J; Kranz B; Bamborschke D; Baig S; Lange-Sperandio B; Jungraithmayr T; Weber LT; Kemper MJ; Tönshoff B; Hoyer PF; Konrad M; Weber S; Clin J Am Soc Nephrol; 2016 Feb; 11(2):245-53. PubMed ID: 26668027 [TBL] [Abstract][Full Text] [Related]
4. Idiopathic nephrotic syndrome in Syrian children: clinicopathological spectrum, treatment, and outcomes. Wannous H Pediatr Nephrol; 2024 Aug; 39(8):2413-2422. PubMed ID: 38587559 [TBL] [Abstract][Full Text] [Related]
5. Rituximab for nephrotic syndrome in children. Iijima K; Sako M; Nozu K Clin Exp Nephrol; 2017 Apr; 21(2):193-202. PubMed ID: 27422620 [TBL] [Abstract][Full Text] [Related]
6. Response to First Course of Intensified Immunosuppression in Genetically Stratified Steroid Resistant Nephrotic Syndrome. Mason AE; Sen ES; Bierzynska A; Colby E; Afzal M; Dorval G; Koziell AB; Williams M; Boyer O; Welsh GI; Saleem MA; Clin J Am Soc Nephrol; 2020 Jul; 15(7):983-994. PubMed ID: 32317330 [TBL] [Abstract][Full Text] [Related]
7. Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study. Taşdemir M; Canpolat N; Yıldız N; Özçelik G; Benzer M; Saygılı SK; Özkayin EN; Türkkan ÖN; Balat A; Candan C; Çelakıl M; Yavuz S; Akıncı N; Göknar N; Akgün C; Tülpar S; Alpay H; Sever FL; Bilge İ Turk J Med Sci; 2021 Aug; 51(4):1781-1790. PubMed ID: 33581711 [TBL] [Abstract][Full Text] [Related]
8. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Guigonis V; Dallocchio A; Baudouin V; Dehennault M; Hachon-Le Camus C; Afanetti M; Groothoff J; Llanas B; Niaudet P; Nivet H; Raynaud N; Taque S; Ronco P; Bouissou F Pediatr Nephrol; 2008 Aug; 23(8):1269-79. PubMed ID: 18465150 [TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome. Fujinaga S; Nishino T; Umeda C; Tomii Y; Watanabe Y; Sakuraya K Pediatr Nephrol; 2019 Feb; 34(2):353-357. PubMed ID: 30426219 [TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol. Ravani P; Bonanni A; Ghiggeri GM BMJ Open; 2017 Mar; 7(3):e013319. PubMed ID: 28314744 [TBL] [Abstract][Full Text] [Related]
11. Does cyclosporine achieve a real advantage for treatment of idiopathic nephrotic syndrome in children? A long-term efficacy and safety study. Sheashaa H; Mahmoud I; El-Basuony F; El-Husseini A; Hassan N; El-Baz M; Ahmed NS; Sobh M Int Urol Nephrol; 2007; 39(3):923-8. PubMed ID: 17447154 [TBL] [Abstract][Full Text] [Related]
12. Rituximab in The Management of Pediatric Steroid-Resistant Nephrotic Syndrome: A Systematic Review. Jellouli M; Charfi R; Maalej B; Mahfoud A; Trabelsi S; Gargah T J Pediatr; 2018 Jun; 197():191-197.e1. PubMed ID: 29680473 [TBL] [Abstract][Full Text] [Related]
13. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome. Wang W; Xia Y; Mao J; Chen Y; Wang D; Shen H; Fu H; Du L; Liu A Pediatr Nephrol; 2012 Nov; 27(11):2073-2079. PubMed ID: 22714672 [TBL] [Abstract][Full Text] [Related]
14. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria. Ladapo TA; Esezobor CI; Lesi FE Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374 [TBL] [Abstract][Full Text] [Related]